Interest in Electronic Applications for Patients With Glaucoma
Overview
To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.
Full Title of Study: “Interest of Patients and Their Caregivers in A Smartphone- and Tablet-Based Application for Patients With Glaucoma”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: October 2016
Detailed Description
This study is designed to determine the amount of interest in an educational application (app) on social media for glaucoma patients and their caregivers. The purpose of this App is to enhance understanding of glaucoma by using short video tutorials. The App will include glaucoma eye drop medication reminders, a short video tutorial which aims to improve understanding of how visual field testing should be performed, how to administer eye drops and a feature that will enable participants to store and organize testing results using a mobile device.
Interventions
- Device: Interest in medical education through social media
- Measuring interest in social media technology designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.
Arms, Groups and Cohorts
- Glaucoma Patients and Caregivers
- Glaucoma patients and caregivers will complete a 20 item questionnaire providing demographic information, glaucoma eye drop compliance, interest in medication reminders, availability to smartphone, tablet and social media technology and interest in using a glaucoma application on social media.
Clinical Trial Outcome Measures
Primary Measures
- Patients Owning Smartphone/Tablet Technology
- Time Frame: 1 hour
- Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
- Patients Having Access to Social Media Via Smartphone or Tablet in the Home
- Time Frame: 1 hour
- Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.
Secondary Measures
- Glaucoma Medication Compliance
- Time Frame: 1 hour
- Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.
- Use of Medication Reminder
- Time Frame: 1 hour
- Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.
Participating in This Clinical Trial
Inclusion Criteria
- Anyone affected by glaucoma – Family and friends of someone with glaucoma Exclusion Criteria:
- unable to complete survey
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Wills Eye
- Provider of Information About this Clinical Study
- Principal Investigator: Jonathon Myers, Principal Investigator – Wills Eye
- Overall Official(s)
- Jonathan S Myers, MD, Principal Investigator, Wills Eye Hospital
Citations Reporting on Results
Waisbourd M, Dhami H, Zhou C, Hsieh M, Abichandani P, Pro MJ, Moster MR, Katz LJ, Hark LA, Myers JS. The Wills Eye Glaucoma App: Interest of Patients and Their Caregivers in a Smartphone-based and Tablet-based Glaucoma Application. J Glaucoma. 2016 Sep;25(9):e787-91. doi: 10.1097/IJG.0000000000000504.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.